David James Dooley,Mark John Field,Richard Griffith Williams
申请号：
US14219351
公开号：
US20140206670A1
申请日:
2014.03.19
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The instant invention relates to a combination, particularly a synergistic combination, of an alpha-2-delta ligand and a dual serotonin-noradrenaline re-uptake inhibitor (DSNRI) or one or both of a selective serotonin re-uptake inhibitor (SSRI) and a selective noradrenaline re-uptake inhibitor (SNRI), and pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof and their use in the treatment of pain, particularly neuropathic pain.
